Figure 2
FFS and OS for patients treated with DHAP (n = 112) or R-DHAP (n = 113) and FFS for patients attaining CR/PR after 2 cycles of (R)-DHAP and (R)-VIM, which was followed by a third chemotherapy cycle and ASCT.
FFS and OS for patients treated with DHAP (n = 112) or R-DHAP (n = 113) and FFS for patients attaining CR/PR after 2 cycles of (R)-DHAP and (R)-VIM, which was followed by a third chemotherapy cycle and ASCT.
